Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms
Ferran Nadeu(Centro de Investigación Biomédica en Red de Cáncer), Tait D. Shanafelt(Mayo Clinic), Renata Walewska(Dorset HealthCare University NHS Foundation Trust), Manuel Cossio(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Guillem Clot(Aristotle University of Thessaloniki), Romina Royo(Barcelona Supercomputing Center), Silvia Martín(Instituto de Investigación Biomédica de Salamanca), Sameer A. Parikh(Mayo Clinic), Frédéric Davi(Sorbonne Université), Livio Trentin(University of Padua), Laura K. Hilton(BC Cancer Agency), Davide Rossi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Ziao Lin(Broad Institute), Ander Díaz‐Navarro(Universidad de Oviedo), Sílvia Ruiz-Gaspà(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Riccardo Moia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Cynthia K. Hahn(Boston University), Pablo Bousquets‐Muñoz(Universidad de Oviedo), Lydia Scarfò(IRCCS Ospedale San Raffaele), Shimin Shuai(Ontario Institute for Cancer Research), Marine Armand(Sorbonne Université), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Andrea Visentin(University of Padua), Marta Kulis(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Michael Doubek(Central European Institute of Technology), Miguel Alcoceba(Instituto de Investigación Biomédica de Salamanca), Viktor Ljungström(Uppsala University), Marta Aymerich(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Zadie Davis(Royal Bournemouth Hospital), Larry Mansouri(Uppsala University), Irene López‐Oreja(Hospital Clínic de Barcelona), Enrique Colado(Hospital Universitario Central de Asturias), Binyamin A. Knisbacher(Broad Institute), Thomas Chatzikonstantinou(G. Papanikolaou General Hospital), Alfredo Rivas‐Delgado(Hospital Clínic de Barcelona), María José Terol(Hospital Clínico Universitario de Valencia), Ángel Ramírez Páyer(Hospital Universitario Central de Asturias), Karla Plevová(Central European Institute of Technology), Marcos González(Complejo Hospitalario de Salamanca), Junyan Lu(Heidelberg University), Cecilia Jylhä(Karolinska Institutet), Kari G. Rabe(Mayo Clinic), Daniel Hägerstrand(Karolinska Institutet), Aron Skaftason(deCODE Genetics (Iceland)), Anna Enjuanes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Tycho Baumann(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Emma Young(Uppsala University), Kamila Stránská(Central European Institute of Technology), Ellen J. van Gastel-Mol(Erasmus MC), Neil E. Kay(Mayo Clinic)
Cited by 2
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
Executive Leadership and Physician Well-being
|Mayo Clinic Proceedings|2016|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k